Geron Corp. : Geron to Present at the Jefferies Global Healthcare Conference

 Geron Corp. : Geron to Present at the Jefferies Global Healthcare Conference

MENLO PARK, Calif., May 28, 2013 - Geron Corporation (Nasdaq: GERN) today
announced that John Scarlett, M.D., President and Chief Executive Officer,
will present an overview of the company at 1:00 p.m. Eastern Time on Thursday,
June 6, at the Jefferies 2013 Global Healthcare Conference in New York City.

A live webcast of the presentation will be available at
http://wsw.com/webcast/jeff77/gern/. Following the live presentation, the
webcast will be archived and available for replay at the same address for a
period of 30 days.

About Geron

Geron is a clinical stage biopharmaceutical company developing a
first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid
malignancies. For more information about Geron, visit www.geron.com.

CONTACT:

Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com

                                     ###

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Geron Corp. via Thomson Reuters ONE
HUG#1705337
 
Press spacebar to pause and continue. Press esc to stop.